UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Form 10-Q
| (Mark one) | ||
|
þ
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
| For the quarterly period ended March 27, 2004 | ||
| or | ||
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
| For the transition period from to | ||
Commission file number: 000-50307
FormFactor, Inc.
| Delaware | 13-3711155 | |
|
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
2140 Research Drive, Livermore, California 94550
(925) 294-4300
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes o No þ
The number of shares of the registrants common stock, par value $0.001 per share, outstanding as of April 30, 2004 was 37,466,484 shares.
FORMFACTOR, INC.
FORM 10-Q FOR THE QUARTERLY PERIOD ENDED MARCH 27, 2004
INDEX
| Page | ||||||||
| 2 | ||||||||
| 2 | ||||||||
| 2 | ||||||||
| 3 | ||||||||
| 4 | ||||||||
| 5 | ||||||||
| 10 | ||||||||
| 30 | ||||||||
| 31 | ||||||||
| 32 | ||||||||
| 32 | ||||||||
| 32 | ||||||||
| 33 | ||||||||
| 33 | ||||||||
| 33 | ||||||||
| 33 | ||||||||
| Signature | 34 | |||||||
| Exhibit Index | 35 | |||||||
| EXHIBIT 31.01 | ||||||||
| EXHIBIT 31.02 | ||||||||
| EXHIBIT 32.01 | ||||||||
1
PART I. FINANCIAL INFORMATION
| Item 1. | Unaudited Condensed Consolidated Financial Statements |
FORMFACTOR, INC.
| Three Months Ended | |||||||||||
| March 29, 2003 | March 27, 2004 | ||||||||||
|
Revenues
|
$ | 18,669 | $ | 37,118 | |||||||
|
Cost of revenues(1)
|
9,800 | 18,026 | |||||||||
|
Gross margin
|
8,869 | 19,092 | |||||||||
|
Operating expenses:
|
|||||||||||
|
Research and development(1)
|
3,525 | 4,349 | |||||||||
|
Selling, general and administrative(1)
|
4,013 | 5,874 | |||||||||
|
Stock-based compensation
|
333 | 409 | |||||||||
|
Total operating expenses
|
7,871 | 10,632 | |||||||||
|
Operating income
|
998 | 8,460 | |||||||||
|
Interest income
|
162 | 533 | |||||||||
|
Interest expense
|
(14 | ) | | ||||||||
|
Other expense
|
(19 | ) | (395 | ) | |||||||
| 129 | 138 | ||||||||||
|
Income before income taxes
|
1,127 | 8,598 | |||||||||
|
Provision for income taxes
|
(428 | ) | (3,422 | ) | |||||||
|
Net income
|
$ | 699 | $ | 5,176 | |||||||
|
Net income per share:
|
|||||||||||
|
Basic
|
$ | 0.15 | $ | 0.14 | |||||||
|
Diluted
|
$ | 0.02 | $ | 0.13 | |||||||
|
Weighted-average number of shares used in per
share calculations:
|
|||||||||||
|
Basic
|
4,539 | 37,083 | |||||||||
|
Diluted
|
29,266 | 40,042 | |||||||||
|
(1) Amounts exclude stock-based compensation
expense, as follows:
|
|||||||||||
|
Cost of revenues
|
$ | 55 | $ | 61 | |||||||
|
Research and development
|
69 | 127 | |||||||||
|
Selling, general and administrative
|
209 | 221 | |||||||||
|
Total
|
$ | 333 | $ | 409 | |||||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
2
FORMFACTOR, INC.
| December 27, | March 27, | |||||||||
| 2003 | 2004 | |||||||||
| ASSETS | ||||||||||
|
Current assets:
|
||||||||||
|
Cash and cash equivalents
|
$ | 116,305 | $ | 99,232 | ||||||
|
Marketable securities
|
62,965 | 82,520 | ||||||||
|
Accounts receivable, net of allowance for
doubtful accounts of $103 in 2003 and 2004
|
19,698 | 26,375 | ||||||||
|
Inventories, net
|
8,025 | 8,744 | ||||||||
|
Deferred tax assets
|
2,575 | 2,523 | ||||||||
|
Prepaid expenses and other current assets
|
2,744 | 2,756 | ||||||||
|
Total current assets
|
212,312 | 222,150 | ||||||||
|
Restricted cash
|
2,550 | 2,550 | ||||||||
|
Property and equipment, net
|
20,495 | 27,374 | ||||||||
|
Deferred tax assets
|
398 | 398 | ||||||||
|
Other assets
|
356 | 349 | ||||||||
|
Total assets
|
$ | 236,111 | $ | 252,821 | ||||||
| LIABILITIES AND STOCKHOLDERS EQUITY | ||||||||||
|
Current liabilities:
|
||||||||||
|
Accounts payable
|
$ | 10,579 | $ | 15,334 | ||||||
|
Accrued liabilities
|
10,147 | 9,032 | ||||||||
|
Deferred revenue and customer advances
|
1,005 | 1,278 | ||||||||
|
Total current liabilities
|
21,731 | 25,644 | ||||||||
|
Deferred revenue and customer advances
|
433 | 374 | ||||||||
|
Total liabilities
|
22,164 | 26,018 | ||||||||
|
Stockholders equity:
|
||||||||||
|
Common stock, $0.001 par value
|
37 | 38 | ||||||||
|
Additional paid-in capital
|
226,630 | 232,950 | ||||||||
|
Notes receivable from stockholders
|
(661 | ) | | |||||||
|
Deferred stock-based compensation, net
|
(11,249 | ) | (10,623 | ) | ||||||
|
Accumulated other comprehensive income (loss)
|
(4 | ) | 68 | |||||||
|
Retained earnings (accumulated deficit)
|
(806 | ) | 4,370 | |||||||
|
Total stockholders equity
|
213,947 | 226,803 | ||||||||
|
Total liabilities and stockholders equity
|
$ | 236,111 | $ | 252,821 | ||||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
3
FORMFACTOR, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
| Three Months Ended | ||||||||||||
| March 29, 2003 | March 27, 2004 | |||||||||||
|
Cash flows from operating
activities:
|
||||||||||||
|
Net income
|
$ | 699 | $ | 5,176 | ||||||||
|
Adjustments to reconcile net income to net cash
used in operating activities:
|
||||||||||||
|
Depreciation and amortization
|
1,281 | 1,380 | ||||||||||
|
Stock-based compensation expense
|
333 | 409 | ||||||||||
|
Deferred tax assets
|
| 52 | ||||||||||
|
Tax benefit from employee stock option plans
|
| 2,524 | ||||||||||
|
Interest income from stockholders notes
receivable
|
(58 | ) | | |||||||||
|
Provision for doubtful accounts
|
(50 | ) | | |||||||||
|
Provision for excess and obsolete inventories
|
1,102 | 656 | ||||||||||
|
Loss on disposal of property and equipment
|
10 | | ||||||||||
|
Changes in assets and liabilities:
|
||||||||||||
|
Accounts receivable
|
1,731 | (6,678 | ) | |||||||||
|
Inventories
|
(1,901 | ) | (1,376 | ) | ||||||||
|
Prepaid and other current assets
|
(356 | ) | (3 | ) | ||||||||
|
Accounts payable
|
(1,641 | ) | (1,951 | ) | ||||||||
|
Accrued liabilities
|
(2,339 | ) | (1,141 | ) | ||||||||
|
Deferred revenues
|
(157 | ) | 213 | |||||||||
|
Net cash used in operating activities
|
(1,346 | ) | (739 | ) | ||||||||
|
Cash flows from investing
activities:
|
||||||||||||
|
Acquisition of property and equipment
|
(960 | ) | (1,560 | ) | ||||||||
|
Purchase of marketable securities
|
(2,810 | ) | (31,060 | ) | ||||||||
|
Proceeds from maturities of marketable securities
|
6,030 | 11,597 | ||||||||||
|
Restricted cash
|
2,835 | | ||||||||||
|
Other assets
|
10 | | ||||||||||
|
Net cash provided by (used in) investing
activities
|
5,105 | (21,023 | ) | |||||||||
|
Cash flows from financing
activities:
|
||||||||||||
|
Proceeds from issuance of common stock, net
|
67 | 4,013 | ||||||||||
|
Repayment of notes receivable from stockholders
|
10 | 661 | ||||||||||
|
Repayment of notes payable
|
(125 | ) | | |||||||||
|
Net cash provided by (used in) financing
activities
|
(48 | ) | 4,674 | |||||||||
|
Effect of exchange rate changes on cash and cash
equivalents
|
12 | 15 | ||||||||||
|
Net increase (decrease) in cash and cash
equivalents
|
3,723 | (17,073 | ) | |||||||||
|
Cash and cash equivalents, beginning of the period
|
26,786 | 116,305 | ||||||||||
|
Cash and cash equivalents, end of the period
|
$ | 30,509 | $ | 99,232 | ||||||||
|
Supplemental disclosure of significant
non-cash investing activities:
|
||||||||||||
|
Purchases of property and equipment through
accounts payable and accrued liabilities
|
$ | | $ | 6,700 | ||||||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
4
FORMFACTOR, INC.
Note 1 Basis of Presentation
The accompanying unaudited condensed consolidated financial statements of FormFactor, Inc. and its subsidiaries (the Company) have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and pursuant to the instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission. Accordingly, the interim financial statements do not include all of the information and footnotes required by generally accepted accounting principles for annual financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the three months ended March 27, 2004 are not necessarily indicative of the results that may be expected for the year ending December 25, 2004, or for any other period. The balance sheet at December 27, 2003 has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. These financial statements and notes should be read with the financial statements and notes thereto for the year ended December 27, 2003 included in the Companys annual report on Form 10-K for the year ended December 27, 2003 filed with the Securities and Exchange Commission.
Note 2 Significant Accounting Policies
The Companys significant accounting policies are disclosed in the Companys annual report on Form 10-K for the year ended December 27, 2003 filed with the Securities and Exchange Commission. The Companys significant accounting policies have not materially changed during the three months ended March 27, 2004.
Note 3 Inventories
Inventories are stated at the lower of cost (principally standard cost which approximates actual cost on a first-in, first-out basis) or market value. Reserves for potentially excess and obsolete inventory are made based on inventory levels and future sales forecasts.
Inventories, net of reserves, consisted of the following (in thousands):
| December 27, | March 27, | |||||||
| 2003 | 2004 | |||||||
|
Raw materials
|
$ | 3,128 | $ | 3,915 | ||||
|
Work-in-progress
|
4,628 | 4,829 | ||||||
|
Finished goods
|
269 | | ||||||
| $ | 8,025 | $ | 8,744 | |||||
Note 4 Warranty
The Company offers warranties on certain products and records a liability for the estimated future costs associated with customer claims, which is based upon historical experience and the Companys estimate of the level of future costs. Warranty costs are reflected in the income statement as a cost of revenues. A
5
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (Continued)
reconciliation of the changes in the Companys warranty liability for the three months ended March 27, 2004 follows (in thousands):
| Three Months Ended | ||||||||
| March 29, | March 27, | |||||||
| 2003 | 2004 | |||||||
|
Beginning balance
|
$ | 679 | $ | 446 | ||||
|
Reserve for warranties issued during the period
|
197 | 196 | ||||||
|
Settlements made during the period
|
(340 | ) | (196 | ) | ||||
|
Ending balance
|
$ | 536 | $ | 446 | ||||
Management believes that the accrual balance at March 27, 2004 is adequate to cover estimated future costs associated with warranty claims.
Note 5 Stock-Based Compensation
The Company uses the intrinsic value method of Accounting Principles Board Opinion No. 25 (APB No. 25), Accounting for Stock Issued to Employees, in accounting for its employee stock options, and presents disclosure of the pro forma information required under SFAS No. 123 (SFAS No. 123), Accounting for Stock-Based Compensation as amended by SFAS No. 148, Accounting for Stock-Based Compensation Transition and Disclosure. The Company uses the Black-Scholes option pricing model to compute its pro forma option expense.
Had compensation cost for the Companys stock option grants to employees been determined based on the fair values of the stock option at the date of grant consistent with the provisions of SFAS No. 123, the Companys net income would have been changed to the pro-forma amounts as follows:
| Three Months Ended | |||||||||
| March 29, | March 27, | ||||||||
| 2003 | 2004 | ||||||||
| (In thousands, except | |||||||||
| per share amounts) | |||||||||
|
Net income, as reported
|
$ | 699 | $ | 5,176 | |||||
|
Add: Stock-based employee compensation expense
included in reported net income, net of tax
|
206 | 246 | |||||||
|
Deduct: Total stock-based employee compensation
expense determined under fair value based method for all awards,
net of tax
|
(265 | ) | (532 | ) | |||||
|
Pro forma net income
|
$ | 640 | $ | 4,890 | |||||
|
Net income per share
|
|||||||||
|
Basic:
|
|||||||||
|
As reported
|
$ | 0.15 | $ | 0.14 | |||||
|
Pro forma
|
$ | 0.14 | $ | 0.13 | |||||
|
Diluted:
|
|||||||||
|
As reported
|
$ | 0.02 | $ | 0.13 | |||||